Part of the Life Sciences Commons
2009
Substituted diphenyl ethers as a broad-spectrum platform for the development of chemotherapeutics for the treatment of tularaemia, Kathleen England, Christopher am Ende, Hao Lu, Todd J. Sullivan, Nicole L. Marlenee, Richard A. Bowen, Susan E. Knudson, Dennis L. Knudson, Peter J. Tonge, Richard A. Slayden
Todd J. Sullivan
2008
Synthesis and in vitro antimycobacterial activity of B-ring modified diaryl ether InhA inhibitors, Christopher W. am Ende, Susan E. Knudson, Nina Liu, James Childs, Todd J. Sullivan, Melissa Boyne, Hua Xu, Yelizaveta Gegina, Dennis L. Knudson, Francis Johnson, Charles A. Peloquin, Richard A. Slayden, Peter J. Tonge
Todd J. Sullivan
2007
Targeting Fatty Acid Biosynthesis for the Development of Novel Chemotherapeutics against Mycobacterium tuberculosis: Evaluation of A-Ring-Modified Diphenyl Ethers as High-Affinity InhA Inhibitors, Melissa E. Boyne, Todd J. Sullivan, Christopher W. amEnde, Hao Lu, Veronica Gruppo, Darragh Heaslip, Anita G. Amin, Delphi Chatterjee, Anne Lenaerts, Peter J. Tonge, Richard A. Slayden
Todd J. Sullivan
2006
High Affinity InhA Inhibitors with Activity against Drug-Resistant Strains of Mycobacterium tuberculosis, Todd J. Sullivan, James J. Truglio, Melissa E. Boyne, Polina Novichenok, Xujie Zhang, Christopher F. Stratton, Huei-Jiun Li, Tejinder Kaur, Amol Amin, Francis Johnson, Richard A. Slayden, Caroline Kisker, Peter J. Tonge
Todd J. Sullivan
